Get set to shimmy on your sofa as Strictly Come Dancing returns to BBC One and BBC iPlayer from Saturday 14 September 2024, marking 20 years of the nation’s favourite dancing show. Made by BBC ...
Dirty Dancing is a 1987 American romance film. Written by Eleanor Bergstein and directed by Emile Ardolino, the film features Patrick Swayze and Jennifer Grey in the lead roles, as well as Cynthia ...
It's a brand new themed week in the Strictly ballroom - here's what the celebs will be dancing to... *JB Gill will dance with Lauren Oakley for Icons Week. A Strictly Come Dancing spokesperson ...
During this week’s “Dancing With the Stars” "Halloween Nightmares" episode, Page Six exclusively caught up with Ilona Maher and Alan Bersten. After the pair reacted to Carrie Ann Inaba’s ...
Longboard Pharmaceuticals (LBPH) on Monday agreed to be acquired by Danish pharmaceutical company H. Lundbeck in a deal with an equity value of about $2.6 billion. Lundbeck will launch a tender ...
Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.
H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is offering ...
Shares of Longboard Pharmaceuticals, Inc. LBPH rose sharply in today's pre-market trading. Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 ...
H. Lundbeck A/S will acquire Longboard Pharmaceuticals for $60 per share in a $2.6 billion deal, closing in Q4 2024. Longboard’s lead asset, bexicaserin, is under development for neurological ...
Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck's $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.
Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the former hoping to build off of its pipeline of epilepsy drug treatment.